(Q43629483)
Statements
1 reference
A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma (English)
1 reference
1 reference
Ferrari AC
1 reference
Chachoua A
1 reference
Singh H
1 reference
Rosenthal M
1 reference
Taneja S
1 reference
Bednar M
1 reference
Mandeli J
1 reference
1 June 2001
1 reference
1 reference
91
1 reference
11
1 reference
2039-2045
1 reference
Identifiers
1 reference
1 reference